Paclitaxel (polymeric micelle formulation) for injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Paclitaxel (polymeric micelle formulation) for injection, covering 2025-06-03 to 2025-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer [Phase 2]